Helsinki’s Algorithmiq Wins €1.7 Million Prize for Quantum-Enabled Light-Sensitive Cancer Drug Discovery
Algorithmiq, a Helsinki‑based quantum software firm, secured the €1.7 million ($2 million) Wellcome Leap prize for demonstrating a practical quantum advantage in drug discovery. The team built an end‑to‑end quantum‑classical workflow that ran on up to 100 qubits to simulate a photosensitiser drug used in photodynamic therapy. Their results matched state‑of‑the‑art classical methods while operating under realistic hardware constraints, proving quantum computing can address real therapeutic challenges. The win caps the €42.3 million ($50 million) Q4Bio challenge, highlighting a shift toward near‑term health applications of quantum tech.
Buckinghamshire Healthcare NHS Trust Becomes First Trust to Sign up to System C’s Ambient AI Consultations
Buckinghamshire Healthcare NHS Trust has become the first NHS organisation to sign a contract with System C to deploy its CareFlow Ambient AI Outpatient Consultations module, slated to go live in summer 2026. The AI‑driven solution will embed real‑time transcription,...
This New Test Could Be a Breakthrough in UTI Treatment
Researchers evaluated an experimental rapid susceptibility test, RMD AST, on 352 urine samples and found it matched standard laboratory cultures 96.95% of the time. The assay delivers results in six hours, a dramatic cut from the typical 48‑72‑hour culture period. Faster,...
AI and Wearables Achieve 90% Accuracy in Predicting Athlete Injuries
AI-powered wearables are now able to predict injuries in athletes with roughly 90% accuracy, according to recent studies. The technology combines motion analysis, training load, sleep quality and recovery data, offering a proactive alternative to traditional reactive sports medicine.
This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster
Formation Bio, backed by Sam Altman and top VCs, has raised $615 million at a $1.8 billion valuation to use AI for faster, cheaper clinical trials. The New York‑based firm plans to acquire a portfolio of about ten early‑stage drug candidates, many stalled...
VR Headset Transports 82‑year‑old Nursing Home Resident to Florence, Boosting Senior Care
Mynd Immersive demonstrated its VR headset to 82‑year‑old Carol Foster at The New Jewish Home, letting her virtually explore Florence. The session underscores how immersive technology is reshaping therapy in senior living facilities across the U.S.
Goodfire AI and the Billion Dollar Bet on Neural Network Interpretability: Why Reverse Engineering Foundation Models Matters for Health Tech...
Goodfire AI, a San Francisco public‑benefit AI lab, raised a $150 million Series B in February 2026, pushing its valuation to $1.25 billion. Its Ember platform gives developers programmatic access to neural‑network internals, claiming a 58% reduction in large‑language‑model hallucinations at roughly 90 × lower...
Pfizer Unveils Nanoparticle Platform to Sharpen Cancer Treatment
Pfizer disclosed a new nanoparticle platform designed to deliver cancer drugs directly to tumors, promising higher precision and fewer side effects. The initiative is led by Puja Sapra, head of the Targeted Therapeutics Unit in Oncology R&D, and is part...
Labcorp and CHOP Launch Pediatric Diagnostics Partnership to Expand Advanced Testing and Drive Clinical Lab Growth
Labcorp and the Children’s Hospital of Philadelphia (CHOP) have formed a strategic partnership to accelerate development and commercialization of pediatric‑specific diagnostics. The collaboration will combine CHOP’s research expertise with Labcorp’s nationwide testing network to bring new molecular and genetic assays...
Can AI Help Us Finally Beat Cancer W/ Dr. Sanjay Juneja, TheOncDoc
In this episode of CareTalk, oncologist Dr. Sanjay Ganesha (TheOncDoc) discusses how advances in AI, immunotherapy, CAR‑T, and early‑detection blood tests are turning cancer from a death sentence into a manageable disease. He shares his personal journey from a vision‑loss...
The Innovators Working to Make in Vivo Cell Therapy a Reality
First‑in‑human trials of in‑vivo CAR‑T therapies are now underway, delivering therapeutic genes directly inside patients via viral or lipid‑nanoparticle vectors. Big‑pharma interest is evident after AstraZeneca’s $1 bn purchase of EsoBiotec and Eli Lilly’s $2.4 bn acquisition of Orna Therapeutics, despite limited clinical...
Heidi Launches First Hardware Designed For Reliable Audio Capture in Every Clinical Setting
UK‑based AI health platform Heidi has launched Heidi Remote, a purpose‑built wearable microphone for reliable audio capture in clinical settings. The device replaces phones and laptops, offering 14 hours of battery life, offline recording, and hospital‑grade durability to improve AI‑scribe transcription...
Weekly Neuroscience Update
Researchers unveiled a fully implantable brain‑computer interface that lets paraplegic patients control a robotic exoskeleton with their thoughts, aiming to restore both walking and its sensation. Parallel advances include an AI pruning framework that mimics infant brain development to slash...
Doctolib, AP-HP, and Roche Launch Startup Programme to Bridge Healthtech–Clinical Gap
Doctolib, AP‑HP’s Hôtel‑Dieu, and Roche have launched Care Forward, a health‑tech accelerator housed at Station F. The program pairs Doctolib’s software know‑how, AP‑HP’s hospital network access, and Roche’s regulatory expertise to help European startups test and scale solutions that measurably...
The Rise of Virtual Therapy Platforms in Healthcare
Virtual therapy platforms have surged into mainstream healthcare, offering patients flexible, cost‑effective mental health care through video, audio, and text channels. The COVID‑19 pandemic accelerated adoption, normalizing remote sessions and prompting providers to integrate digital tools. Advances such as AI‑driven...
Resilience by Design: Building a National Network for Ambulance Services
The Ambulance Radio Programme (ARP) has built a national, dual‑data‑centre network that links 35 NHS trust sites, ensuring 24/7 availability of mission‑critical ambulance communications. Partnering with Vysiion, ARP introduced a dedicated Network Operations Centre and managed services to monitor, patch,...
ApoQlar's MR Tools Revolutionize Surgical Planning
I've come across many mixed reality applications for pre- and post-operative planning, but it seems like this one just levelled up the game. ApoQlar Medical has developed MR applications for surgeons, medical students, and patients alike. Check out how a surgeon can...
Automating Behavioral Health Utilization Review to Reduce Denials
A Johns Hopkins study found that 1 in 10 U.S. adults experienced a mental‑health crisis in 2025, underscoring soaring demand for behavioral health services. Most facilities still rely on manual utilization review (UR) using spreadsheets and shared inboxes, which creates...
£1m Longitude Prize Awarded to “Revolutionary” AI Smart Glasses Companion for People Living with Dementia
The Longitude Prize on Dementia awarded a £1 million (~$1.25 million) grand prize to CrossSense for its AI‑powered smart‑glasses companion, Wispy. The device uses computer‑vision and voice prompts to identify objects and guide early‑stage dementia patients through daily routines, learning each user’s...
![[Emergency Pod] Peptides - Part 1 with Sunita Mohanty of Ultralight](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://megaphone.imgix.net/podcasts/d0db1eda-2c6f-11ef-958d-9fb4aba9c1ce/image/0bfc12f76c8a92fdb53253e1c884033d.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress)
[Emergency Pod] Peptides - Part 1 with Sunita Mohanty of Ultralight
In this episode of Lifers, host Christina Farr talks with Sunita Mohanty, CEO and co‑founder of Ultralight, about the booming interest in peptide therapies for wellness and longevity. Sunita explains that while peptides are gaining popularity—driven by anecdotal success, recent...
NTU's AI Chip Detects Disease Biomarkers in 20 Minutes and More Briefs
Researchers at Singapore’s NTU unveiled an AI‑enabled nanophotonic chip that detects microRNA disease biomarkers in about 20 minutes, bypassing traditional PCR methods. South Korea’s Neurophet raised $21.6 million to expand its AI brain‑imaging platform for Alzheimer’s and other neuro‑conditions, targeting the...
Philips Receives US FDA 510(k) Clearance for AI-Powered Spectral CT Verida System
Philips has obtained FDA 510(k) clearance for its Verida spectral CT system, the world’s first AI‑powered detector‑based spectral CT platform. The system combines always‑on spectral imaging with deep‑learning reconstruction, delivering higher image quality, lower noise, and enhanced tissue characterization. It...
PET‑CT Leak Linked to Staff Cancer Cases
The 3D precision of a PET-CT scan is designed to find cancer, but at one government teaching hospital, the machine itself is being blamed for causing it. Seven personnel in a single radiology department have developed cancer or thyroid diseases. You...
Hippocratic AI Launches Safety-First Voice AI for Patients and Nurses
Healthcare AI startup Hippocratic AI unveiled two voice‑driven solutions: AI Front Door, a patient‑facing omni‑topic agent, and Nurse Co‑Pilot, a bedside assistant for inpatient nurses. AI Front Door consolidates scheduling, lab results, billing and care follow‑ups into a single, relationship‑based...
'Self-Regulating' Wound Patch Developed in South Korea
Researchers at KAIST unveiled a self‑regulating wound‑healing patch that merges a 630‑nm organic LED with a ROS‑triggered drug delivery system. The OLED emits uniform light to stimulate cell regeneration while nanocarriers release Centella asiatica extract in proportion to the generated...
Establishing 5G Connectivity to Enable a Smart Regional Health System
Singapore’s National University Health System (NUHS) has signed a strategic agreement with GSMA Foundry to embed private 5G across its hospital cluster. The partnership will integrate 5G private networks with digital twins, XR, IoT and ambient AI to accelerate remote...
Novo Nordisk Partners with OpenAI to Speed AI-Driven Drug Discovery
Novo Nordisk has struck a partnership with OpenAI to use generative AI for drug discovery, aiming to cut development timelines. The announcement lifted Novo’s stock 2.8% and intensifies its race with Eli Lilly for a share of the $100 bn obesity market.
Mount Sinai Adopts SOPHiA GENETICS AI Platform to Boost Precision Cancer Care
Mount Sinai Health System announced it will adopt SOPHiA GENETICS' AI‑powered DDM platform to enhance genomic testing for blood cancers and solid tumors. The partnership, unveiled at the AACR 2026 meeting, adds the New York health system to a network...
Matternet and SoftBank Robotics America Partner to Accelerate Drone Delivery Networks
Matternet and SoftBank Robotics America have formed a strategic partnership to commercialize autonomous drone delivery for healthcare, retail and enterprise logistics. The alliance will combine Matternet's certified drone platform with SoftBank's manufacturing and rollout capabilities, targeting rapid deployment of end‑to‑end...
Nix Biosensors Teams with Baylor Athletics for Campus‑Wide Real‑Time Hydration Monitoring
Nix Biosensors has signed a two‑year agreement with Baylor University to equip all 19 Division‑I programs and roughly 450 student‑athletes with its Nix Pro wearable, delivering individualized, real‑time sweat and electrolyte data. The partnership aims to transform hydration protocols, reduce...
Lunit's AI Breast Imaging Hits 330+ Sites, Powers 1 Million Annual Screenings
Lunit announced that its AI‑powered breast imaging suite is deployed at more than 330 screening locations across the Americas, processing roughly one million mammograms each year. The rollout includes a full‑scale enterprise deployment at Lexington Clinic and FDA clearance of...
Wellcome Leap Announces $2M Prize in $50M Quantum for Bio Challenge Program
Wellcome Leap announced that Algorithmiq earned the $2 million prize in its $50 million Quantum for Bio (Q4Bio) Challenge, marking the first end‑to‑end quantum‑classical workflow that simulates a photosensitizer drug for photodynamic cancer therapy. The program, launched in 2023, devoted $40 million to...
Northwestern Engineers 3D‑Print Artificial Neurons That Communicate With Living Brain Cells
Northwestern University engineers printed flexible artificial neurons that generate realistic electrical spikes and successfully activated living mouse brain cells. The work, published in Nature Nanotechnology, showcases a new class of printable, low‑cost neural interfaces that could reshape neuroprosthetics and brain‑inspired...
AI Creates Orexin Activator to Boost Focus, Reduce Sleep
Two researchers just used AI to design a selective orexin activator. If you care about focus, steady energy, or needing less sleep, this is worth paying attention to. https://t.co/3qbzB6J7X3
Cala Secures FDA Clearance for Next‑Gen TAPS Wearable Targeting Tremor in ET and Parkinson's
Cala Health announced FDA clearance of its next‑generation kIQ Plus wearable neurostimulation system for essential tremor and Parkinson's disease. The device introduces new therapy modes and adaptive calibration, and will be showcased with clinical data at the American Academy of...
Whoop Launches Deep‑Dive Health Panels for Personalized Insights
Introducing Specialized Panels on Whoop 🙌🏼 Now available through @whoop Advanced Labs, powered by Quest. These panels focus on specific areas like metabolic health, heart health, performance, and men’s and women’s health. The goal is simple: go a level deeper than...
Sharp HealthCare Taps Apple Vision Pro for Surgical Innovation
Sharp HealthCare in San Diego has launched an IRB‑approved clinical study to evaluate Apple’s Vision Pro headset in cataract surgery. The feasibility and safety study will measure how spatial‑computing tools affect depth perception, workflow efficiency, and surgeon ergonomics. Conducted at Sharp...
Whoop Wants to Test Your Blood
Whoop is expanding its health platform with Specialized Panels, a set of five targeted blood‑test packages that measure 75‑89 biomarkers. Priced at $299 per panel, the tests are offered as one‑time purchases through Quest Diagnostics and sync results directly into...
Wisp, Visby Partner to Expand Access to At-Home STI Test
Wisp has partnered with Visby Medical to offer Visby’s at‑home PCR test for chlamydia, gonorrhea and trichomoniasis. The palm‑sized test costs $149.99, delivers results in 30 minutes via a mobile app, and is FDA‑authorized. Positive results trigger free virtual follow‑up...
New Guidelines Recommend AI-Based Breast Cancer Risk Assessments
The National Comprehensive Cancer Network’s 2026 Clinical Practice Guidelines now recommend image‑based artificial‑intelligence risk assessments as a primary tool for breast cancer screening. The guidance advises using AI‑derived five‑year risk scores from routine mammograms, with a 1.7 % risk threshold prompting...
Designing Implants that Don’t Scar the Brain
A new study systematically compared stiff silicon electrodes with flexible polyimide probes for intracortical neural implants. The researchers found that material choice dominates tissue response: polyimide probes trigger far less scarring and inflammation than silicon, while probe thickness or wireless...
A Single Measurement Sorts Chiral Molecules by Type, Handedness, and Ratio
Researchers have unveiled a terahertz circular dichroism platform that uses an achiral gradient metasurface to identify chiral biomolecules, their handedness, and mixing ratios in a single broadband scan. The metasurface reflects terahertz light from 0.5 to 1.8 THz without adding background...
Kennedy: 90% Of FDA Reviewers Are Using AI For Faster Drug Approvals
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. told the House Ways & Means Committee that more than 90% of FDA reviewers are now using artificial‑intelligence tools to speed drug approvals. The AI applications are also being rolled...
FDA Clears First AI-Enabled, Detector-Based Spectral CT System
Philips received FDA 510(k) clearance for its Verida spectral CT system, the first AI‑enabled, detector‑based scanner of its kind. The platform combines a dual‑layer Nano‑panel detector with AI‑driven image reconstruction, delivering always‑on spectral imaging without extra scans. Verida can reconstruct...
Nanoz Rolls Out AI‑powered 2 Mm Nanosensors for Health and Environmental Monitoring
Nanoz, a French deep‑tech company, announced the industrial launch of AI‑enabled nanosensors no larger than 2 mm. The devices combine metal‑oxide semiconductor gas detection with machine‑learning algorithms to identify disease biomarkers, cabin‑air hazards and urban pollutants, opening new markets in healthcare,...
Researchers Encode Full Hepatitis D Genome on IBM Quantum System One
Scientists from the Wellcome Sanger Institute, Oxford, Cambridge, Melbourne and Kyiv Academic University have loaded a complete Hepatitis D virus genome onto IBM Quantum System One’s 156‑qubit Heron processor. The milestone, achieved under the Wellcome Leap‑funded Q4Bio Challenge, demonstrates that...
OpenAI Unveils GPT‑Rosalind for Pharma Drug Discovery
I truly believe OpenAI is hoping to drive a ton of revenue based on what it can do with health/medical -> OpenAI launches GPT-Rosalind, an AI model for life sciences research, including drug discovery, as a research preview for customers...
Another Win for Opportunistic Screening: AI Turns Head CT Scans Into Heart Assessments
Researchers at Harvard Medical School have trained deep‑learning models on nearly 100,000 head CT scans to predict cardiovascular disease (CVD) risk and estimate coronary artery calcium (CAC) scores. The AI‑derived CVD timing model outperformed the American Heart Association’s PREVENT risk...
Staging, ctDNA, and the Art of Personalizing Metastatic Breast Cancer Therapy: Hayley Knollman, MD
Hayley M. Knollman, MD, highlighted how estrogen‑receptor‑positive metastatic breast cancer still relies on conventional staging—blood work, imaging, and tissue biopsies—while emerging HER2‑low categories gain relevance only after disease spreads. She noted that circulating tumor DNA (ctDNA) and broad genomic panels are now...
AI Documentation Seen as a ‘Competitive Advantage’ in Hospice Regulatory Labyrinth
Hospices are turning to artificial‑intelligence documentation platforms to ease staffing shortages and meet mounting Medicare audit demands. Dr. Brian Haas, national medical director at Ascend Hospice, argues that precise, rapid documentation will become a measurable competitive advantage. While AI can...